Evidence map›Paper›PMID 26283961›Full record

ArticleFrontiers in pharmacology2015

A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children.

Jeffrey S Barrett, Sarapee Hirankarn, Nick Holford, Gregory B Hammer, David R Drover, Carol A Cohane, Brian Anderson, Erin Dombrowski, Tammy Reece, Anne Zajicek and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Jeffrey S BarrettClinical Pharmacology and Therapeutics Division, The Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania Medical School Philadelphia, PA, USA.
Sarapee HirankarnClinical Pharmacology and Therapeutics Division, The Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania Medical School Philadelphia, PA, USA.
Nick HolfordDepartment of Pharmacology and Clinical Pharmacology and Anesthesia, University of Auckland Auckland, New Zealand ; Department of Anesthesia, University of Auckland Auckland, New Zealand.
Gregory B HammerDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine Stanford, CA, USA.
David R DroverDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine Stanford, CA, USA.
Carol A CohaneDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine Stanford, CA, USA.
Brian AndersonDepartment of Anesthesia, University of Auckland Auckland, New Zealand.
Erin DombrowskiClinical Pharmacology and Therapeutics Division, The Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania Medical School Philadelphia, PA, USA.
Tammy ReeceDuke Clinical Research Institute, Duke University Medical Center Durham, NC, USA.
Anne ZajicekThe Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health Bethesda, MD, USA.
Scott R SchulmanDuke Clinical Research Institute, Duke University Medical Center Durham, NC, USA.
Children's Hospital of Philadelphia · USStanford University · USUniversity of Auckland · NZClinical Research Institute · USDuke Medical Center · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sodium nitroprusside (SNP) has been widely used to control blood pressure in infants and children. The goals of this analysis were to develop models that describe the hemodynamic response to SNP dosing in pediatric patients; examine sources of variation in dose-response, defining age, and size dependencies; and determine vulnerable populations or patient subtypes that may elicit dosing modifications. A multi-center, randomized, double-blinded, parallel-group, dose-ranging, effect-controlled study, followed by an open-label dose titration of an intravenous infusion of SNP was undertaken in 203 pediatric subjects, who required deliberate hypotension or controlled normotension during anesthesia. A total of 3464 MAP measurements collected from 202 patients during the study's blinded phase, including baseline measurements up to 6 min prior to the blinded were available for analysis. A population K-PD model was developed with a one-compartment model assumed for SNP. Size differences in CL and V of the effect compartment were described using theory-based allometry. An inhibitory sigmoidal Emax model was used to describe the effect of SNP. A power function of age was used to describe age-related differences in baseline MAP. A mixture model of two groups with low and high EC50 was used to explain variability in MAP response. Change in MAP was characterized by a linear disease progression slope during the blinded phase. In the final population model, CL and V increased with weight, and baseline MAP increased with age. The effect compartment half-life of SNP was 13.4 min. The infusion rate producing 50% of Emax (ER50) at steady state for high EC50, was 0.34 μg/kg/min and for low EC50 0.103 μg/kg/min. The K-PD model well-describes initial dosing of SNP under controlled circumstances; model-based dosing guidance agrees with current practice. An initial titration strategy supported via algorithm-based feedback should improve maintenance of target MAP.

Indexed as

biologicalcontrolledhemodynamicshypotensionmodelspediatricssodium nitroprusside

Identifiers

PMID26283961
PMCPMC4516882
OpenAlexW1481215652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.